Skip to main content
. 2021 Nov 8;14:7895–7905. doi: 10.2147/IJGM.S335968

Table 2.

Comparison of Mean Non-COVID Hospitalizations per Week According to APRDRG During the First and Second Waves

APRDRG Mean Hospitalizations per Week During the First Wave Mean Hospitalizations per Week During the Second Wave
Baseline Early COVID-19 P valuea Peak COVID-19 P valueb Late COVID-19 P valuec Baseline Early COVID-19 P valuea Peak COVID-19 P valueb Late COVID-19 P valuec
053 Seizure 12 11 0.98 6 0.06 8 0.99 11 10 0.98 10 0.99 10 0.99
058 Other disorders of nervous system 7 5 0.54 1 <0.01 3 0.97 7 7 0.99 4 0.22 5 0.99
073 Eye procedures except orbit 8 7 0.86 2 0.01 3 0.99 7 6 0.92 3 <0.01 3 0.99
098 Other ear, nose, mouth & throat procedures 9 7 0.81 2 <0.01 2 0.99 10 8 0.92 4 <0.01 4 0.99
115 Other ear, nose, mouth, throat & cranial/facial diagnoses 12 11 0.99 3 <0.01 4 0.99 17 15 0.99 7 <0.01 9 0.98
139 Other pneumonia 9 12 0.53 4 0.36 3 0.99 7 4 0.22 3 0.09 3 0.99
144 Respiratory signs, symptoms & minor diagnoses 8 8 0.99 3 0.17 2 0.99 8 9 0.99 4 0.18 4 0.99
163 Cardiac valve procedures w/o AMI or complex PDX 6 4 0.57 3 0.11 4 0.97 6 6 0.98 2 <0.01 2 0.99
175 Percutaneous coronary intervention w/o AMI 22 20 0.99 6 <0.01 14 0.19 23 23 0.99 16 0.02 18 0.95
181 Lower extremity arterial procedures 8 6 0.86 2 <0.01 3 0.99 8 7 0.96 5 <0.01 4 0.99
191 Cardiac catheterization for coronary artery disease 9 8 0.99 1 0.01 2 0.99 8 8 0.99 6 0.36 8 0.8
192 Cardiac catheterization for other non-coronary conditions 16 14 0.91 3 <0.01 7 0.92 16 17 0.98 8 <0.01 10 0.93
194 Heart failure 9 7 0.74 4 0.02 6 0.86 8 7 0.97 5 0.13 6 0.99
225 Appendectomy 5 2 0.48 3 0.63 4 0.99 5 6 0.99 6 0.84 5 0.84
254 Other digestive system diagnoses 8 6 0.6 3 <0.01 4 0.98 7 5 0.26 6 0.49 6 0.99
301 Hip joint replacement 8 7 0.99 2 0.04 4 0.98 9 8 0.99 3 <0.01 4 0.99
302 Knee joint replacement 9 8 0.99 1 0.02 2 0.99 10 10 0.99 3 <0.01 2 0.99
313 Knee & lower leg procedures except foot 7 7 0.99 1 0.1 4 0.86 6 8 0.03 4 0.53 3 0.98
443 Kidney & urinary tract procedures for non-malignancy 8 5 0.74 3 0.06 4 0.99 8 8 0.99 4 0.03 5 0.95
463 Kidney & urinary tract infections 5 3 0.71 3 0.39 4 0.99 7 5 0.77 4 0.02 4 0.99
513 Uterine & adnexa procedures for non-malignancy except leiomyoma 8 6 0.79 0 0.05 3 9 8 0.99 2 <0.01 4 0.98
540 Cesarean delivery 8 10 0.87 7 0.93 7 0.99 8 6 0.35 8 0.99 6 0.82
560 Vaginal delivery 22 19 0.9 22 0.99 25 0.97 25 22 0.7 23 0.87 21 0.99
640 Neonate birthwt >2499 g, normal newborn or neonate 26 27 0.99 26 0.99 29 0.94 29 26 0.82 28 0.99 24 0.71
696 Other chemotherapy 14 16 0.92 16 0.99 14 0.99 17 18 0.99 17 0.99 16 0.99
720 Septicemia & disseminated infections 6 5 0.78 5 0.91 4 0.97 7 5 0.41 4 0.26 3 0.99
772 Alcohol & drug dependence w rehab, detox, therapy 7 8 0.99 0 <0.01 0 8 7 0.99 4 <0.01 0
861 Signs, symptoms & other factors influencing health status 11 8 0.97 2 0.16 4 0.99 9 9 0.99 5 <0.01 6 0.98
862 Other aftercare & convalescence 15 13 0.97 2 0.06 12 0.57 18 18 0.99 9 <0.01 6 0.72
951 Moderately extensive procedure unrelated to principal diagnosis 10 7 0.18 2 <0.01 5 0.5 10 9 0.99 7 0.61 4 0.76

Notes: aComparison of early COVID-19 admissions to baseline admissions. bComparison of peak COVID-19 admissions to baseline admissions. cComparison of late COVID-19 admissions to peak COVID-19 admissions.